ACTO Named a Luminary in Everest Group’s “Innovation Watch: Agentic AI in Life Sciences Commercial 2026”
Recognition highlights ACTO’s role-based SuperAgents, cross-platform orchestration, and Life Sciences-focused approach to governed agentic AI TORONTO and NEW YORK, Oct. 5, 2026 /PRNewswire/ — ACTO, uniting human intelligence with empathetic AI in
